COO Strangle Strategy
COO (The Cooper Companies, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
COO (The Cooper Companies, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $11.60B, a trailing P/E of 29.14, a beta of 0.89 versus the broader market, a 52-week range of 58.89-89.83, average daily share volume of 2.1M, a public-listing history dating back to 1983, approximately 16K full-time employees. These structural characteristics shape how COO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.89 places COO roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on COO?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current COO snapshot
As of May 15, 2026, spot at $59.66, ATM IV 44.90%, IV rank 16.95%, expected move 12.87%. The strangle on COO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on COO specifically: COO IV at 44.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a COO strangle, with a market-implied 1-standard-deviation move of approximately 12.87% (roughly $7.68 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated COO expiries trade a higher absolute premium for lower per-day decay. Position sizing on COO should anchor to the underlying notional of $59.66 per share and to the trader's directional view on COO stock.
COO strangle setup
The COO strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With COO near $59.66, the first option leg uses a $62.64 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed COO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 COO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $62.64 | N/A |
| Buy 1 | Put | $56.68 | N/A |
COO strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
COO strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on COO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on COO
Strangles on COO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the COO chain.
COO thesis for this strangle
The market-implied 1-standard-deviation range for COO extends from approximately $51.98 on the downside to $67.34 on the upside. A COO long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current COO IV rank near 16.95% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on COO at 44.90%. As a Healthcare name, COO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to COO-specific events.
COO strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. COO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move COO alongside the broader basket even when COO-specific fundamentals are unchanged. Always rebuild the position from current COO chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on COO?
- A strangle on COO is the strangle strategy applied to COO (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With COO stock trading near $59.66, the strikes shown on this page are snapped to the nearest listed COO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are COO strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the COO strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 44.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a COO strangle?
- The breakeven for the COO strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current COO market-implied 1-standard-deviation expected move is approximately 12.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on COO?
- Strangles on COO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the COO chain.
- How does current COO implied volatility affect this strangle?
- COO ATM IV is at 44.90% with IV rank near 16.95%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.